Spyre Therapeutics (SYRE)
Nasdaq • SYRE • US00773J2024
99.04Last close
Market Closed
Nasdaq • SYRE • US00773J2024
Spyre Therapeutics (Nasdaq: SYRE) has a market capitalization of $9.41B. Last close $99.04 (as of 2026-11-05); 52-week range $21.15 to $110.18. ORTEX data as of 2026-11-03: short interest is 16.16% of free float, 10.9 days to cover and the average cost to borrow is 0.47%.